RedHill Biopharma (RDHL) Shares Outstanding (2022 - 2024)

RedHill Biopharma (RDHL) has disclosed Shares Outstanding for 3 consecutive years, with $12.9 billion as the latest value for Q4 2024.

  • Quarterly Shares Outstanding rose 1.2% to $12.9 billion in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $12.9 billion through Dec 2024, up 1.2% year-over-year, with the annual reading at $12.9 billion for FY2024, 1.2% up from the prior year.
  • Shares Outstanding for Q4 2024 was $12.9 billion at RedHill Biopharma, up from $12.7 billion in the prior quarter.
  • The five-year high for Shares Outstanding was $12.9 billion in Q4 2024, with the low at $1.2 billion in Q4 2022.
  • Average Shares Outstanding over 3 years is $8.9 billion, with a median of $12.7 billion recorded in 2023.
  • The sharpest move saw Shares Outstanding skyrocketed 980.5% in 2023, then grew 1.2% in 2024.
  • Over 3 years, Shares Outstanding stood at $1.2 billion in 2022, then surged by 980.5% to $12.7 billion in 2023, then rose by 1.2% to $12.9 billion in 2024.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $12.9 billion, $12.7 billion, and $1.2 billion for Q4 2024, Q4 2023, and Q4 2022 respectively.